A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.
Clinical trial NCT01789099 · COMPLETED
Trial details
- NCT number
- NCT01789099
- Sponsor
- Ultimovacs ASA
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-08
- Primary completion
- 2016-02-29
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.